Voyager Therapeutics - 4 Year Stock Split History | VYGR

Stock split history for Voyager Therapeutics since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Voyager Therapeutics Annual Stock Splits
Voyager Therapeutics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.791B $0.008B
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.911B 9.47
Mylan (MYL) United Kingdom $9.559B 4.21
Bausch Health Cos (BHC) Canada $7.495B 5.00
Teva Pharmaceutical Industries (TEVA) Israel $6.999B 2.75
Dr Reddy's Laboratories (RDY) India $5.851B 19.69
ASPEN PHARMACR (APNHY) South Africa $2.022B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.422B 13.90
Amphastar Pharmaceuticals (AMPH) United States $1.010B 49.72
Homology Medicines (FIXX) United States $0.738B 0.00
CymaBay Therapeutics (CBAY) United States $0.400B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.343B 0.47
Akorn (AKRX) United States $0.341B 0.00
Assembly Biosciences (ASMB) United States $0.321B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.320B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.260B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.178B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.093B 0.00
Teligent (TLGT) United States $0.037B 0.00